HugoScore hugoscore.org

Mental health AI

Ash

Ash offers patient-chosen mental health conversations. Published conditions describe opt-in improvement use, whose implementation was not tested. Its qualified agency finding does not establish clinical effectiveness or control over every therapeutic goal.

AI-assisted draft Read full report Open directory

Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.

70 /100 toward patient-directed
Agency posture Mixed, access gains with unproven clinical claims
The question we ask Who does Ash serve in this deployment?
Control Slingshot AI's adult consumer emotional-support app, with self-directed or AI-guided conversations. Vendor-controlled self-help service, not professional therapy or crisis response.
Agency read Mixed, access gains with unproven clinical claims
Vendor
Slingshot AI, Inc.
Who it serves
Patient-directed consumer mental health chatbot, vendor-controlled and venture-funded, with contested clinical positioning
Primary User
Adults 18 and older seeking emotional support, self-reflection, and everyday mental health help
Control Model
Vendor-hosted public service. Controls and downstream processors depend on the assessed deployment.
Patient Impact
Reflection and pattern suggestions may expand understanding, but claims that an AI has found a personal pattern need inspectable evidence and opportunities to disagree. Friendly language and engagement are insufficient proof.
Profile Status
AI-assisted draft
Last assessed
Sep 8, 2026
Review Confidence
Medium for updated rights and scope (AI-assisted draft)
AI / Model
OpenAI Codex / GPT-6
Human Review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Summary judgment · 70 out of 100 toward patient-directed

Slingshot AI's adult consumer emotional-support app, with self-directed or AI-guided conversations. Vendor-controlled self-help service, not professional therapy or crisis response.

Mixed, access gains with unproven clinical claims

Ash offers patient-chosen mental health conversations. Published conditions describe opt-in improvement use, whose implementation was not tested. Its qualified agency finding does not establish clinical effectiveness or control over every therapeutic goal.

Patient agency

How this tool changes agency

Expands agency when

Reflection and pattern suggestions may expand understanding, but claims that an AI has found a personal pattern need inspectable evidence and opportunities to disagree. Friendly language and engagement are insufficient proof.

Limits agency when

Actual consent defaults, editing or rejecting stored insights, generated-output portability, pricing by region, and independent evidence beyond the bounded index review.

Patient agency assessment

Who sets and changes the goal?

Patient authority

Users can set the agenda and decline training participation as documented. No direct mechanism for overriding persistent psychological characterizations was established.

What can the patient understand, question, or do?

Critical capacity

Reflection and pattern suggestions may expand understanding, but claims that an AI has found a personal pattern need inspectable evidence and opportunities to disagree. Friendly language and engagement are insufficient proof.

Can the patient evaluate the conditions of use?

Informed control

The revised policy and EULA are materially clearer about data use. Generated-content reuse and the basis of personal insights remain less clear than input ownership.

Text findings

Conditions of use

Published controls and their limits

The revised policy and EULA are materially clearer about data use. Generated-content reuse and the basis of personal insights remain less clear than input ownership.

What remains unknown?

Not tested or not established

Actual consent defaults, editing or rejecting stored insights, generated-output portability, pricing by region, and independent evidence beyond the bounded index review.

Who evaluated this?

AI-assisted public-source draft

Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.

Sources checked

Source-specific findings and retrieval limitations are recorded in the full report.

Review provenance

Criteria

CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.

Reviewer

AI-assisted public-source reassessment prepared in OpenAI Codex.

AI / model

OpenAI Codex / GPT-6

Human review

Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.

Review date

2026-09-08

Limitations

Actual consent defaults, editing or rejecting stored insights, generated-output portability, pricing by region, and independent evidence beyond the bounded index review. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.

Review method

Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.

AI-assisted draft · Medium for updated rights and scope (AI-assisted draft)